Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by jfogarty12on Feb 07, 2020 7:54pm
87 Views
Post# 30661123

RE:Vivo down 1%

RE:Vivo down 1%you want DOWN TRY THIS ONE:

bleak outlook  at least Vivo is not in this boat!


Aurora shares hit two-year-low as analysts cast sweeping downgrade 

Shares of Aurora Cannabis plunged on Friday following the pot giant’s massive corporate update that revealed the company’s CEO, Terry Booth, is stepping down and that the pot producer will write down nearly $1 billion in assets. Not surprisingly, analysts are skeptical that Aurora can achieve its cost-cutting goals. At least four sell-side analysts downgraded their ratings on the company’s stock, while many also reduced their 12-month price targets on Aurora shares. BMO Capital Markets’ Tamy Chen said she remains cautious that Aurora can achieve positive cash flows by the time the company’s at-the-market equity program is used up.

<< Previous
Bullboard Posts
Next >>